Skipping breast surgery for some patients after chemo
Part of Cancer, Skin clinical trials.
This trial tests whether women with certain aggressive breast cancers (HER2-positive without hormone receptors, or triple-negative) can safely skip breast surgery if chemotherapy makes their tumor completely disappear. The goal is to avoid surgery and its side effects when it may no longer be needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 70 years old
- You have either HER2-positive breast cancer that is hormone-receptor negative, or triple-negative breast cancer
- Your tumor was small (T1 or T2) and has not spread to lymph nodes (N0) at diagnosis
- Your overall health is good enough for daily activities (ECOG 0 or 1)
- Your heart function is normal (LVEF 50% or higher, and a normal heart rhythm check)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if a breast biopsy can confirm that chemo has destroyed all cancer cells, so you might avoid surgery altogether. It's for people with aggressive breast cancer types who responded well to chemotherapy.
This study tests whether some patients with early-stage, hormone-positive breast cancer can safely skip chemotherapy and just use hormone therapy plus a CDK4/6 inhibitor pill after surgery. If you qualify, you may avoid chemo side effects while still reducing the chance of the cancer coming back.
This trial tests whether women who have a complete response to chemotherapy before breast-conserving surgery can safely skip a special radiation boost to the tumor bed. It aims to reduce unnecessary treatment side effects while maintaining good outcomes.
This trial tests if it's safe to skip a sentinel lymph node biopsy (a procedure to check if cancer has spread to the lymph nodes under your arm) when the breast tumor has completely disappeared after chemotherapy. If the trial finds it's safe, you could avoid this extra surgery and its side effects.
This trial tests whether it's safe to skip armpit surgery in people whose breast cancer has responded well to chemotherapy and whose lymph nodes appear cancer-free on ultrasound. It aims to reduce side effects like arm swelling while still controlling the cancer.
This trial is for women 50 and older with early-stage, hormone-positive or HER2-positive breast cancer. It tests whether it is safe to skip radiation therapy after a lumpectomy if an MRI before surgery shows the breast tissue looks a certain way.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.